Interestingly, the expression of CEACAM5 and 6 is upregulated by SMAD3-mediated TGF-β signaling, suggesting a link between the metastatic properties of TGF-β in cancer and CEACAMs [109]. The gene discussed is TGFB1; the disease is cancer.